Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IPRAGLIFLOZIN L-PROLINE: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

37.6%
Female
62.4%
Male

Age Information

The average age of patients reporting adverse events with IPRAGLIFLOZIN L-PROLINE is 62.1 years.

Geographic Distribution

The majority of adverse event reports for IPRAGLIFLOZIN L-PROLINE originate from JP.

Report Summary & Outcomes

124
Total Reports
124
As Primary/Secondary Suspect
9
Deaths Reported
74
Hospitalizations
7
Life-Threatening
7
Disabilities

Reporting Timeline

First adverse event report: 20130523. Most recent report: 20241001. View full timeline →

More About IPRAGLIFLOZIN L-PROLINE

IPRAGLIFLOZIN L-PROLINE Full Profile Reports by Year Drug Interactions